Company: Wave Life Sciences
Job title: Vice President, Bioanalytical, Pharmacology & Biomarker Development
Dr. Jaya Goyal is leading bioanalytical, DMPK, clinical pharmacology and biomarker activities to support the preclinical and clinical development of nucleic acid therapeutics at Wave Life Sci., Cambridge Massachusetts. The group is involved in the development and validation of pharmacokinetic, anti-drug antibody and biomarker assays, pre-clinical and clinical pharmacokinetic assessments, tissue distribution, in-vitro stability, plasma protein binding, metabolite ID, species comparison, PK/PD correlations, data modeling and simulations for projection of human doses and frequencies. Her group is also responsible for biomarker strategies and translational medicine approaches for patient stratification and personalized medicine. Prior to joining Wave Life Sci., Jaya was at Biogen for 16 years, where, in her most recent role as Senior Director, she was a member of cross-functional innovation hub, Value Based Medicine (VBM), focused on improving decision making and clinical care for Multiple Sclerosis (MS) patients. Jaya Goyal received her Ph.D. degree in Biochemistry from Central Drug Research Institute, India in 1993 and did her post-doctoral training at the Rush Presbyterian St. Luke’s Medical Center, Chicago and New England Medical Center, Boston.